Gregory L. Verdine
Affiliations: | Chemistry and Chemical Biology | Harvard University, Cambridge, MA, United States |
Area:
control of gene expression and preservation of genomic integrityWebsite:
http://www.fas.harvard.edu/~biophys/Gregory_L_Verdine.htmGoogle:
"Gregory Verdine"Bio:
http://verdinelab.harvard.edu/
http://www.scrb.harvard.edu/lab/646/home
http://www.n-of-one.com/about/science-medical-advisors.php
Mean distance: 6.66
Parents
Sign in to add mentorKoji Nakanishi | grad student | 1986 | Columbia | |
(Binding of mitomycin C to a dinucleoside phosphate and DNA) | ||||
Christopher T. Walsh | post-doc | 1988 | Harvard |
Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Callahan AJ, Gandhesiri S, Travaline TL, et al. (2024) Mirror-image ligand discovery enabled by single-shot fast-flow synthesis of D-proteins. Nature Communications. 15: 1813 |
Tokareva OS, Li K, Travaline TL, et al. (2023) Recognition and reprogramming of E3 ubiquitin ligase surfaces by α-helical peptides. Nature Communications. 14: 6992 |
Li K, Tokareva OS, Thomson TM, et al. (2022) De novo mapping of α-helix recognition sites on protein surfaces using unbiased libraries. Proceedings of the National Academy of Sciences of the United States of America. 119: e2210435119 |
Shigdel UK, Ovchinnikov V, Lee SJ, et al. (2020) The trajectory of intrahelical lesion recognition and extrusion by the human 8-oxoguanine DNA glycosylase. Nature Communications. 11: 4437 |
Shigdel UK, Lee SJ, Sowa ME, et al. (2020) Genomic discovery of an evolutionarily programmed modality for small-molecule targeting of an intractable protein surface. Proceedings of the National Academy of Sciences of the United States of America |
Chatterjee N, D'Souza S, Shabab M, et al. (2020) A Stapled POL κ Peptide Targets REV1 to Inhibit Mutagenic Translesion Synthesis. Environmental and Molecular Mutagenesis |
Stewart ML, Perl NR, Lee S, et al. (2020) Abstract B37: Development of inhibitors of the activated form of KRAS G12C Molecular Cancer Research. 18 |
Lee SJ, Sung RJ, Verdine GL. (2019) Mechanism of DNA Lesion Homing and Recognition by the Uvr Nucleotide Excision Repair System. Research (Washington, D.C.). 2019: 5641746 |
Mitra S, Montgomery JE, Kolar MJ, et al. (2017) Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer. Nature Communications. 8: 660 |
Levinson AM, McGee JH, Roberts AG, et al. (2017) Total Chemical Synthesis and Folding of All-L and All-D Variants of Oncogenic KRas(G12V). Journal of the American Chemical Society |